Tuesday, December 28, 2010

The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses

The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses

Although the history of the biotechnology industry dates back to the late 19th century, It was only much later that biological organisms began to be modified for applications in agriculture, industrial production and medicine. The medical application of biotechnology began in earnest in the 1970s, growth has been strong as novel new medicines have been approved for conditions not previously treatable with conventional pharmaceuticals. Because they are biologically-derived but used for similar purposes as pharmaceutical products, these medications are also referred to as “biopharmaceuticals”.
Biopharmaceuticals can be defined as therapeutics manufactured by biotechnology methods from biological sources, usually involving live organisms or their active components (bioprocessing, or directly involving surrogates, e.g., protein/gene sequences).
For the purpose of this report, biopharmaceuticals include the following broad therapeutic classes which can be further divided into other sub-classes:
Monoclonal antibodies;
Therapeutic proteins (inclusive of Insulin and analogs, erythropoietins, interferon alpha, interferon beta, blood coagulation factors, human growth hormone, enzymes, follicle stimulating hormone)
Vaccines (inclusive of vaccines manufactured only by recombinant technology)
Monoclonal antibodies were the largest sub-category, accounting for approximately half  of the global biotechnology market in 2009. Hormones such as insulin & analogs, human growth hormone, and follicle stimulating hormone were the second largest sub-category. Growth factors, including erythropoietin and granulocyte colony stimulating factors were the third largest sub-category. Interferons, comprising of interferons alpha and beta were the fourth largest sub-category. The fifth in order were coagulation factors such as blood factors and coagulants. The last two sub-categories were of therapeutic enzymes and recombinant vaccines.
Key Features
  • Overview of the global biotech industry
  • Impact of the US healthcare reform on the biotech industry
  • Market dynamics and performance of key sub-categories in 2009
  • Detailed profiles of the top 10 global biotech players
  • Strategic growth analyses and SWOT analyses of the top 10 global biotechnology players
  • Short profiles of other leading players
Key Benefits
  • Understand the dynamics of the global biotech market.
  • Develop insights into leading sub-categories of the global biotech market, including monoclonal antibodies, hormones, growth factors, interferons, enzymes and vaccines.
  • Examine the competitive landscape of the global biotech industry.
  • Analyze individual SWOT analyses  of key players in the global biotech industry.
  • Gauge the sales performance and growth strategies of leading companies in global biotech market.
Highlights of the report
Roche was the leading biotechnology company in the world generating $33bn in sales in 2009, at a Y-o-Y growth of 8.2% and a market share of 35.4%.
The global biotechnology market generated $94.7bn in 2009 sales, demonstrating a Y-o-Y growth of 10.7%. The period from 2005 to 2009 was a lucrative period for the biotechnology market as it increased at a CAGR of 12.4%.
Neulasta, Enbrel and Epogen represented Amgen’s top three brands in 2009. The top 10 brands in the company’s portfolio accounted for 88.8% of its total sales in 2009.
Key questions answered by this report
  • What are the key trends in the global biotech industry?
  • Which were the leading players in the global biotech market?
  • Which companies will drive the future of the global biotech market?
  • What are the key strengths, weaknesses, threats, and opportunities for the leading global biotech players?
  • How was the sales performance of leading players in the global biotech market post recent economic downturn?
  • Which companies have the most promising pipeline products in the biotech industry?
  • What are the growth strategies being implemented by leading biotech companies such as Roche, Amgen, Gilead, UCB and Biogen?
Buy Now: Market Research

Related Reports

at